1841 related articles for article (PubMed ID: 6100609)
1. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
2. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
3. Captopril: pharmacology, metabolism and disposition.
Migdalof BH; Antonaccio MJ; McKinstry DN; Singhvi SM; Lan SJ; Egli P; Kripalani KJ
Drug Metab Rev; 1984; 15(4):841-69. PubMed ID: 6437780
[TBL] [Abstract][Full Text] [Related]
4. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
5. Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat.
Berecek KH; Nagahama S; Oparil S
J Hypertens Suppl; 1984 Dec; 2(3):S63-6. PubMed ID: 6100756
[TBL] [Abstract][Full Text] [Related]
6. [Cardiovascular effects of ketamine anesthesia in rats treated with enalapril and propranolol].
Reyes Toso CF; Linares LM; Rodríguez RR
Medicina (B Aires); 1992; 52(3):240-4. PubMed ID: 1342690
[TBL] [Abstract][Full Text] [Related]
7. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
Baum T; Watkins RW; Sybertz EJ; Ahn HS; Nelson S; Coleman W; Tedesco R; Pula KK; Rivelli M; Sabin C
Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):230-45. PubMed ID: 2884941
[TBL] [Abstract][Full Text] [Related]
9. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
11. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
12. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Dzau VJ
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
Sweet CS
Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
[TBL] [Abstract][Full Text] [Related]
14. Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy.
Gröne HJ; Helmchen U
Lab Invest; 1986 Jun; 54(6):645-55. PubMed ID: 3012198
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure responses to enalapril in rats with one- and two-kidney DOC-NaCl hypertension.
Arvola P; Nurmi AK; Säynävälammi P; Manninen V; Vapaatalo H
Methods Find Exp Clin Pharmacol; 1989 Feb; 11(2):67-71. PubMed ID: 2540388
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension.
Arendshorst WJ; Chatziantoniou C; Daniels FH
Kidney Int Suppl; 1990 Nov; 30():S92-6. PubMed ID: 2259085
[TBL] [Abstract][Full Text] [Related]
18. Physiological responses to angiotensin II infusion during chronic angiotensin converting enzyme inhibition in dogs on normal, low and high sodium intake.
Olsen ME; Meydrech EF
J Hypertens; 1985 Oct; 3(5):517-25. PubMed ID: 2999230
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II blockade and the functions of the renin-angiotensin system.
Davis JO; Freeman RH; Watkins BE; Stephens GA; Williams GM
Prog Biochem Pharmacol; 1976; 12():1-15. PubMed ID: 798202
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
Laubie M; Schiavi P; Vincent M; Schmitt H
J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
